Skip to content
10-K

Annual Report

INNOVATION PHARMACEUTICALS INC.

0001477932-22-007292

← back to feed
Filed
Sep 28, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Sep 22, 2022 488.23M sh
Rd Expense FY 2022 · Jun 30, 2022 $7K
Rd Expense FY 2022 · Jun 30, 2021 $7.02M
Net Income FY 2022 · Jun 30, 2022 $63K
Net Income FY 2022 · Jun 30, 2021 −$13.87M
Operating Income FY 2022 · Jun 30, 2022 $62K
Operating Income FY 2022 · Jun 30, 2021 −$9.02M
Operating Cash Flow FY 2022 · Jun 30, 2021 −$9.5M
Cash And Equivalents FY 2022 · Jun 30, 2021 $10.19M
Cash And Equivalents FY 2022 · Jun 30, 2020 $6.02M
Current Liabilities FY 2022 · Jun 30, 2021 $6.54M
Total Liabilities FY 2022 · Jun 30, 2021 $6.79M
Current Assets FY 2022 · Jun 30, 2021 $10.69M
Total Assets FY 2022 · Jun 30, 2021 $14.3M
Sga Expense FY 2022 · Jun 30, 2021 $963K
Revenue FY 2022 · Jun 30, 2021 $0
Stockholders Equity FY 2022 · Jun 30, 2020 $1.46M